Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genfit S.A. ADR (NQ: GNFT )

4.200 -0.040 (-0.94%)
Streaming Delayed Price Updated: 3:12 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genfit S.A. ADR

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! We're kicking off the day with a dive into some of the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains... 
Via Benzinga
Why Genfit Shares Are Rising
Genfit SA (NASDAQ: GNFT) shares are trading higher after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. David Loew, Chief Executive... 
Via Benzinga
Dreaming Of A Red Christmas
The stock market is reacting with lots of selling to the weekend's news. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021
Upgrades According to Keefe, Bruyette & Woods, the prior rating for Old National Bancorp (NASDAQ:... 
Via Benzinga
63 Biggest Movers From Friday
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... 
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Drops Over 2%; Bottomline Technologies Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 0.87% to 35,585.26 while the NASDAQ rose 0.43% to 15,245.07. The S&P also fell, dropping 0.32% to 4,653.92. The U.S. has... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Genfit (NASDAQ:GN... 
Via Benzinga
Major Benchmarks Mixed With Weekly Losses Likely
The Dow Jones Industrial Average is extending this morning's losses,the S&P 500 Index has joined the Dow in the red, while the Nasdaq Composite has managed to climb back above its breakeven 
Via Talk Markets
Mid-Day Market Update: Dow Tumbles 500 Points; Abeona Therapeutics Shares Plummet
Midway through trading Friday, the Dow traded down 1.39% to 35,398 while the NASDAQ fell 0.30% to 15,134.89. The S&P also fell, dropping 0.92% to 4,625.58. The U.S. has the... 
Via Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc... 
Via Benzinga
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
Genfit (GNFT) stock is rocketing higher on Friday after the company signed an exclusive licensing agreement with Ipsen (IPSEY). 
Via InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Darden Restaurants Posts Upbeat Earnings
Following the market opening Friday, the Dow traded down 1.33% to 35,420.19 while the NASDAQ fell 0.61% to 15,082.68. The S&P also fell, dropping 1% to 4,622.16. The U.S. has... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Genfit (NASDAQ:GNFT) stock moved upwards by 38.55% to $4.6 during Friday's pre-market session. The market value of their outstanding shares is at $210.4... 
Via Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday! 
Via InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. (... 
Via Benzinga
Genfit Shares Rally After Ipsen Buys Rights To Its Late-Stage Kidney Disease Treatment Hopeful
Ipsen SA (OTC: IPSEY) has entered into a long-term strategic partnership to develop, manufacture, and commercialize and Genfit SA's (NASDAQ: GNFT)... 
Via Benzinga
Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership
From Ipsen and GENFIT
Via Business Wire
Uncertain Times
The UK inflation rate last month was 5.1%, not a good omen. 
Via Talk Markets
To sell or not to sell?
Pfizer says its covid pill is 90% effective. PFE got higher target prices from Berenburg and Mizuho 
Via Talk Markets
Happy December
Inflation levels this year will almost certainly lower growth in 2022 because of inflation this year in everything from house prices....to stock prices. 
Via Talk Markets
Friday Markets Coverage
Today markets are suffering alongside Austria which locked down against Covid-19 again. 
Via Talk Markets
Exposures COVID-19
Europe's Unicorns
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit. 
Via Talk Markets
Earnings Scheduled For September 29, 2021
Companies Reporting Before The Bell • AGM Gr Hldgs (NASDAQ:AGMH) is estimated to report earnings for its first quarter. • Palatin Technologies (AMEX:PTN) is... 
Via Benzinga
Know When To Hold 'Em, Know When To Fold 'Em ...
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
Working Hard
Today's market was mostly very bipolar with good news bulls getting honey and no news bears none. 
Via Talk Markets
News Overload
Today US markets managed a rally despite misses in both the growth and employment data. 
Via Talk Markets
Full News Day
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
Exposures Fossil Fuels
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.